AI-Based Virtual Screening of NLRP3 Inflammasome-Targeting Drug Candidates for Alzheimer’s Disease and Evaluation of Blood–Brain Barrier Permeability. EMSGH [Internet]. 2026 Oct. 29 [cited 2026 Oct. 31];3:38-47. Available from: https://journals.zeuspress.org/index.php/EMSGH/article/view/1628